15.41 -0.30 (-1.91%)
Pre-Market: 8:27AM EST
Previous Close | 16.71 |
Open | 16.99 |
Bid | 15.38 x 1200 |
Ask | 15.41 x 3000 |
Day's Range | 13.78 - 17.00 |
52 Week Range | 1.95 - 32.29 |
Volume | 30,474,988 |
Avg. Volume | 23,739,881 |
Market Cap | 4.956B |
Beta (5Y Monthly) | 2.64 |
PE Ratio (TTM) | 52.54 |
EPS (TTM) | 0.30 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Canadian weed giant Tilray (NASDAQ: TLRY) was on a tear for much of 2020. Investors have a lot to be thrilled about with Tilray, the most promising of which is its substantial international presence, which will become a game-changer as more countries legalize the recreational and medical use of cannabis. Let's investigate how Tilray can capitalize on marijuana's entry to the mainstream.
The Canadian pot stock rose amid a Reddit-fueled rally and positive earnings results from Tilray, which will merge with Aphria next quarter.
After soaring to all-time highs last month, exchange traded funds tracking cannabis stocks are coming back down to test a key support line.